[at noodls] – SCHAUMBURG, Ill., Nov. 28, 2012 (GLOBE NEWSWIRE) — Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Nafcillin for Injection, USP, in two vial presentations and one pharmacy bulk … moreView todays social media effects on SGNTView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – SCHAUMBURG, Ill., Nov. 13, 2012 (GLOBE NEWSWIRE) — Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Acetazolamide for Injection, USP, the generic form of the carbonic anhydrase … moreView todays social media effects on SGNTView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – Record Revenue and Product Approvals Drive Improved Performance SCHAUMBURG, Ill., Nov. 8, 2012 (GLOBE NEWSWIRE) — Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced financial results for the quarter … moreView todays social media effects on SGNTView the latest stocks trending across Twitter. Click to view dashboard […]
[ACN Newswire] – By David MoskowitzSpectrum Pharmaceuticals (NASDAQ:SPPI) reported adjusted 3Q 2012 earnings per share (EPS) of $0.42, beating the Consensus estimate of $0.27. Revenues for the period came in at $69.0 million … moreView todays social media effects on SGNTView the latest stocks trending across Twitter. Click to view dashboard […]
[ACN Newswire] – By David MoskowitzShares of Spectrum Pharmaceuticals (NASDAQ:SPPI) have been under pressure as investors await the supply of generic leucovorin to increase and compete with SPPI’s branded cancer treatment, … moreView todays social media effects on SGNTView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – SCHAUMBURG, Ill., Oct. 29, 2012 (GLOBE NEWSWIRE) — Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Leucovorin Calcium for Injection, a folic acid derivative, and an adjuvant in … moreView todays social media effects on SGNTView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – SCHAUMBURG, Ill., Oct. 3, 2012 (GLOBE NEWSWIRE) — Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Caffeine Citrate Injection, USP and Caffeine Citrate Oral Solution, USP, central … moreView todays social media effects on SGNTView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – SCHAUMBURG, Ill., Sept. 28, 2012 (GLOBE NEWSWIRE) — Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Vancomycin Hydrochloride for Injection, USP, an anti-infective, in a 5 gram … moreView todays social media effects on SGNTView the latest stocks trending across Twitter. Click to view dashboard […]
